Page last updated: 2024-08-23

ursodeoxycholic acid and Hyperglycemia

ursodeoxycholic acid has been researched along with Hyperglycemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Ghaffar, A; Ahmed, EK; Ghanem, HM; Hassanin, OA; Mohamed, RG1
Bisson, WH; Cai, J; Chen, B; Deng, Y; Gao, X; Ge, P; Gonzalez, FJ; Jiang, C; Krausz, KW; Lian, G; Liu, C; Liu, J; Nichols, RG; Patterson, AD; Rimal, B; Shi, J; Sun, L; Wang, G; Wang, X; Wu, Q; Wu, Y; Xia, J; Xie, C; Yun, C; Zhang, H; Zhang, S; Zhang, X1
Clemens, DL; Dey, A; Kumar, SM; Swaminathan, K1
Cao, A; Chen, X; Chu, S; Guo, H; Peng, W; Wang, L; Zhang, X1
Ishii, S; Ohta, T; Sakai, K; Shiraishi, M; Tsuchida, T1

Other Studies

5 other study(ies) available for ursodeoxycholic acid and Hyperglycemia

ArticleYear
Ursodeoxycholic acid suppresses the formation of fructose/streptozotocin-induced diabetic cataract in rats.
    Fundamental & clinical pharmacology, 2018, Volume: 32, Issue:6

    Topics: Animals; Antioxidants; Cataract; Diabetes Mellitus, Experimental; Disease Models, Animal; Fructose; Glutathione; Hyperglycemia; Insulin; Lens, Crystalline; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Ursodeoxycholic Acid

2018
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.
    Nature medicine, 2018, Volume: 24, Issue:12

    Topics: Bacteroides; Bile Acids and Salts; Diabetes Mellitus, Type 2; Diet, High-Fat; Gastrointestinal Microbiome; Gene Expression Regulation, Bacterial; Glucose Intolerance; Humans; Hyperglycemia; Metabolome; Metagenomics; Metformin; Obesity; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid

2018
GSH protects against oxidative stress and toxicity in VL-17A cells exposed to high glucose.
    European journal of nutrition, 2015, Volume: 54, Issue:2

    Topics: Acetylcysteine; Alcohol Dehydrogenase; Antimetabolites; Antioxidants; Apoptosis; Buthionine Sulfoximine; Cell Survival; Clone Cells; Cytochrome P-450 CYP2E1; Glucose; Glutathione; Hep G2 Cells; Hepatocytes; Humans; Hyperglycemia; Lactoylglutathione Lyase; Maleates; Oxidative Stress; Reactive Oxygen Species; Recombinant Proteins; Ursodeoxycholic Acid

2015
Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress.
    Biological & pharmaceutical bulletin, 2016, Aug-01, Volume: 39, Issue:8

    Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Blood Glucose; Catalase; Cell Survival; Cells, Cultured; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Hyperglycemia; Kidney; Male; Malondialdehyde; Mice; Mice, Mutant Strains; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase; Ursodeoxycholic Acid

2016
Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Metabolism: clinical and experimental, 2012, Volume: 61, Issue:7

    Topics: Animals; Cholagogues and Choleretics; Cholesterol; Diabetes Mellitus, Type 2; Diet, High-Fat; Endoplasmic Reticulum Stress; Fatty Acids; Fatty Liver; Gene Expression Profiling; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Lipid Metabolism; Male; Mice; Phosphorylation; Up-Regulation; Ursodeoxycholic Acid

2012